← Back to news

Markets

Palm Valley Capital Fund Sold Seaboard Corporation (SEB) as It Exceeded the Valuation

Y

This ‘Strong Buy’ Stock Is Trading at New 20-Year Highs

Y

Why Jumia Technologies Rocketed 35% Higher in September

Y

Analyst With $100 Price Target on Nike (NKE) Explains Why He Likes The Stock

Y

Wall Street Loves This 1 New IPO Stock. Should You?

Y

Northrop Grumman Stock Rises. Why Shares Can Hit $700.

Y

Why QuantumScape Stock Jumped Again Today

Y

Cramer Endorsed ONEOK as it Completes $3 Billion Public Offering

Y

Continued Challenges Affected Flowers Foods (FLO) in Q3

Y

The S&P 500 and Nasdaq Are Doing Something That Hasn’t Been Done Since 2011

Y

Realty Income, One of Cramer’s Favorites, Issues $800 Million Notes

Y

Goldman Sachs on the one thing that could turn the rally into a bubble

Y

Cramer Backs Sempra as LNG Expansion and $10 Billion Deal Boost Outlook

Y

What to Expect From Brown & Brown's Next Quarterly Earnings Report

Y

Joby, Archer Aviation Stocks Drop. Tesla’s News Was Only About EVs.

Y

Cramer Stands Firm on American Electric Power Despite Target Cuts and Debt Issue

Y

Cramer Backs BlackRock as Citi Raises Target and GIP Eyes $40 B Deal

Y

PNC Gains Cramer’s Nod After FirstBank Acquisition and Analyst Upgrades

Y

Cramer’s ‘Absolute Favorite’ AbbVie Rises After Study Completions and Upgrade

Y

Stock Market Today: Chipmaker Rally, FOMC Minutes Lift S&P 500 and Nasdaq Composite to Record Close

Y

Cramer Backs Home Depot for Housing Recovery Despite ICE Raid Controversy

Y

Citigroup Gains Momentum on Banamex Sale and Analyst Upgrades as Cramer Stays Bullish

Y

Cramer Backs GE Vernova Amid Turbine Setback and Analyst Downgrade

Y

Bank of America Gains Jim Cramer’s Backing Amid Fintech Funding and Strong Institutional Support

Y

ArcelorMittal, SoftBank, Verisure: Stocks Worldwide in Focus

Y

NVIDIA Gains Cramer’s Backing with OpenAI Partnership and Next-Gen Chip Confidence

Y

FCA proposes compensation scheme for unfair motor finance agreements

Y

Bitcoin ETF 7-Day Inflow Streak Tops $5B, Outpacing September Within a Week

Y

Amdocs (DOX) Fell Despite Delivering Steady Gains

Y

Healthcare Stocks Are Rising: Here Are 2 With Even More Upside Ahead

Y

Diamondback Energy, Inc. (FANG) Expects the Growth of U.S. Crude Production to Stagnate; Bernstein SoGen Group Reiterates Its Outperform Rating and $192 Price Target

Y

Baker Hughes Company (BKR) to Provide Liquefaction Equipment for Sempra Infrastructure’s Port Arthur LNG Phase 2 Project in Texas

Y

Constellation “cautiously optimistic” on macro challenges having reached bottom

Y

AI Can Guide Investment Decisions, But Not Push the Button

Y

Mizuho Reiterates Its Neutral Rating and $133.00 Price Target on EOG Resources, Inc. (EOG)

Y

UBS Retains Its Buy Rating and $158 Price Target for Deckers Outdoor Corporation (DECK)

Y

What Makes Teleflex (TFX) an Investment Choice?

Y

U.S. Navy Awards General Dynamics Corporation (GD) a $698 Million Contract; Seaport Global Securities Upgrades from Neutral to Buy with PT $376

Y

Evercore ISI Downgrades The Allstate Corporation (ALL) from Outperform to In Line

Y

SoftBank bulks up its robotics portfolio with ABB Group’s robotics unit

Y

Jefferies Reduces Its Price Target for Accenture Plc. (ACN) from $260 to $250, Keeps a Hold Rating

Y

Exxon Mobil Corporation (XOM) to Cut 10% of Its Singaporean Personnel by the End of 2027

Y

Keefe, Bruyette & Woods Raises Its Price Target on The Progressive Corporation (PGR), Keeps Market Perform Rating

Y

Iraq signs deal with Exxon to help develop large oilfield

Y

Adobe Inc. (ADBE) Released Its Premiere Video Editing Software for iPhone; Morgan Stanley Reduces PT to $450

Y

JPMorgan Increases Its Price Target for Alibaba Group Holding (BABA), Reiterates its Overweight Rating

Y

Your Boss Might Be ‘Working From Yacht’

Y

What Makes Old Dominion Freight Line (ODFL) an Investment Bet?

Y

UBS Maintains Its Buy Rating on Comfort Systems USA, Inc. (FIX) with $875.00 Price Target

Y

Verona Pharma plc (VRNA)’s Shareholders Authorizes the $10 Billion Acquisition of Verona Pharma plc (VRNA); Nasdaq Trading to Suspend

Y